0.6975
Xilio Therapeutics Inc (XLO) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
175.90%
8.084
|
2.93 | 1.724 | 2.263 | 2.357 |
|
33.78%
22.45
|
16.78 | 15.35 | 17.02 | 17.06 |
Benefits Costs and Expenses |
100.00%
-
|
16.20 | 14.82 | - | - |
Costs And Expenses |
38.62%
22.45
|
16.20 | 14.82 | 17.02 | 17.06 |
Operating Income/Loss |
3.72%
-14.37
|
-13.85 | -13.63 | -14.76 | -14.70 |
Nonoperating Income/Loss |
352.22%
-1.478
|
0.586 | 0.536 | 0.742 | 0.779 |
Income/Loss From Continuing Operations Before Tax |
160.94%
8.084
|
-13.27 | -13.09 | 2.263 | 2.357 |
Income/Loss From Continuing Operations After Tax |
19.44%
-15.84
|
-13.27 | -13.09 | -14.02 | -13.93 |
|
19.44%
-15.84
|
-13.27 | -13.09 | -14.02 | -13.93 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
29.11%
96.45
|
74.70 | 3.7486 | 63.47 | 57.76 |
Basic Earnings Per Share |
11.11%
-0.16
|
-0.18 | -0.18 | -0.22 | -0.24 |
Diluted Earnings Per Share |
11.11%
-0.16
|
-0.18 | -0.18 | -0.22 | -0.24 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):